Short Description

Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Serum antibodies to Cyclic citrullinated peptides (Anti CCP) are now recognised to be a valuable marker of diagnostic and prognostic significance. ANA's occur both in systemic and organ specific autoimmune diseases showing positivity in Rheumatoid arthritis. There is incremental value in testing for presence of both Rheumatoid factor (RF) and Anti CCP as some patients with RA are positive for RF but negative for Anti CCP and vice versa.

PreTest Information

No special preparation required

Detail Description

RHEUMATOID ARTHRITIS PANEL Test: Symptoms, Diagnosis and Cost in India

Rheumatoid Arthritis (RA) is a chronic autoimmune disease that primarily affects the joints and causes inflammation, pain, and stiffness. It is estimated that about 1% of the world's population suffers from RA, with women being more susceptible to the disease than men. Early diagnosis and treatment can help manage the symptoms and prevent joint damage. One of the diagnostic tools available is the Rheumatoid Arthritis Panel test, which measures various markers in the blood that are associated with RA.

Symptoms of Rheumatoid Arthritis

The symptoms of RA can vary from person to person, but the most common ones include:

• Pain, stiffness, and swelling in the joints, especially in the hands, wrists, and feet
• Fatigue and weakness
• Fever and loss of appetite
• Joint deformity and limited range of motion
• Weight loss and anemia

If you are experiencing any of these symptoms, it is important to consult a doctor for a proper diagnosis and treatment.

Diagnosis of Rheumatoid Arthritis

The diagnosis of RA involves a combination of medical history, physical examination, and laboratory tests. The doctor will ask about your symptoms, perform a physical examination, and may order imaging tests such as X-rays, CT scans, or MRI to check for joint damage. The Rheumatoid Arthritis Panel test is a blood test that measures various markers that are associated with RA, such as:

• Rheumatoid factor (RF) - an antibody that is present in about 80% of people with RA
• Anti-cyclic citrullinated peptide (anti-CCP) - an antibody that is present in about 60-70% of people with RA
• C-reactive protein (CRP) - a protein that is present in the blood during inflammation
• Complete blood count (CBC) - a test that measures the number of red and white blood cells in the blood

The results of the Rheumatoid Arthritis Panel test, along with other diagnostic tests, can help confirm a diagnosis of RA and determine the severity of the disease.

Rheumatoid Arthritis Panel Test Cost in India

The cost of the Rheumatoid Arthritis Panel test in India varies depending on the location and the laboratory. On average, the cost of the test is around INR 4500. It is important to note that the cost may vary depending on the additional tests that are ordered along with the Rheumatoid Arthritis Panel test. It is recommended to consult with your doctor or the laboratory to get an accurate estimate of the cost of the test.

Conclusion

Rheumatoid Arthritis is a chronic autoimmune disease that affects the joints and can cause pain, stiffness, and swelling. Early diagnosis and treatment can help manage the symptoms and prevent joint damage. The Rheumatoid Arthritis Panel test is a blood test that measures various markers associated with RA and can help confirm a diagnosis. The cost of the test in India is around INR 4500, but it may vary depending on the location and additional tests ordered. If you are experiencing any symptoms of RA, it is important to consult a doctor for a proper diagnosis and treatment.

At DNA Labs India, we offer a range of diagnostic tests, including the Rheumatoid Arthritis Panel test, to help diagnose and manage various health conditions. Contact us to learn more about our services.

Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Serum antibodies to Cyclic citrullinated peptides (Anti CCP) are now recognised to be a valuable marker of diagnostic and prognostic significance. ANA's occur both in systemic and organ specific autoimmune diseases showing positivity in Rheumatoid arthritis. There is incremental value in testing for presence of both Rheumatoid factor (RF) and Anti CCP as some patients with RA are positive for RF but negative for Anti CCP and vice versa.